Mitsubishi Tanabe Pharma Development America, Inc.

NJ · United States · Reporting entity ID 100000191781

Total reported 2019–2025

$19.3M

#329 of 2,960 reporting companies — 0% of all reported industry payments

$329K in general payments across 379 records, plus $19.0M in research funding across 743 records.

How it breaks down

General payments $328,634

Research funding $18,974,740

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.